by Eric Christianson | Jun 7, 2023 | Clinical Pharmacy News and New Drug Updates
A new SGLT2i is now on the market, promoting a new option for diabetes management. Bexagliflozin (Brenzavvy) got FDA approval in January of this year adding it to the list of SGLT2 inhibitors. With a few already on the scene, it bears the question, is bexagliflozin...
by Eric Christianson | Jun 4, 2023 | Clinical Pharmacy News and New Drug Updates
Earlier this month the FDA approved Rexulti (Brexpiprazole) for the treatment of agitation in patients with dementia due to Alzheimer’s. Originally approved as an atypical antipsychotic used for schizophrenia, or an adjunct therapy for major depressive disorder,...
by Eric Christianson | May 31, 2023 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Buspirone is an anti-anxiety medication that can be used for chronic management. I’ll outline some of the most important clinical pearls and share some anecdotal education in this blog post. The Good – Buspirone Clinical Pearls Buspirone is well tolerated...
by Eric Christianson | May 28, 2023 | Free Clinical Practice Quizzes and Videos For Pharmacists
We have had a wonderful response to our previous pharmacology crossword on diabetes so I figured I try this again. With the help of a pharmacy student, Kevin Laspa, we have created a free hypertension pharmacology crossword puzzle! (ANSWERS AT THE BOTTOM OF THIS POST)...
by Eric Christianson | May 24, 2023 | Personal Stories From The Front Lines of Clinical Pharmacy
Common sense tells us that the more pills a patient takes, the more likely they are to forget or not follow a treatment regimen as prescribed. There is no doubt in reviewing the literature that this has been proven. For my personal knowledge, I wanted to know the...
